Company Filing History:
3 out of 1,217 
1 out of 4 Years Active: 1995-2003
Title: The Innovative Contributions of Phillip D Markham
Introduction
Phillip D Markham is a notable inventor based in Rockville, MD (US), recognized for his significant contributions to the field of biomedical research. With a total of 4 patents, his work primarily focuses on therapeutic compositions and methods for treating viral infections, particularly those related to HIV.
Latest Patents
Markham's latest patents include groundbreaking inventions such as the use of macrophage derived chemokine (MDC) as an anti-viral agent for the treatment and prevention of lentivirus infection. This invention details therapeutic compositions of MDC and methods for treating and preventing infections by lentivirus, especially HIV. It also discusses the use of MDC as a prognostic indicator for HIV infection, providing valuable insights into detection and prognosis. Another significant patent involves molecular clones of HIV-1 viral strains MN-ST1 and BA-L, which are essential for developing vaccines and bioassays for detecting HIV-1 infection in biological samples.
Career Highlights
Throughout his career, Markham has worked with esteemed organizations, including the United States of America as represented by the Department of Health and Biomérieux, Inc. His innovative research has contributed to advancements in the understanding and treatment of viral infections.
Collaborations
Markham has collaborated with prominent figures in the field, including Robert C Gallo and Marvin S Reitz, Jr. These collaborations have further enhanced the impact of his research and inventions.
Conclusion
Phillip D Markham's contributions to biomedical research and his innovative patents have made a significant impact in the fight against viral infections. His work continues to inspire advancements in therapeutic methods and detection techniques.